CGEM Cullinan Oncology LLC

USD 15.61 -0.34 ( -2.13)%
Icon

Cullinan Oncology LLC (CGEM) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 15.61

-0.34 (-2.13)%

N/A

0.26M

USD 32.55(+108.49%)

N/A

Icon

CGEM

Cullinan Oncology LLC (USD)
COMMON STOCK | NSD
USD 15.61
-0.34 ( -2.13)%
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

N/A

N/A

USD 15.61

Cullinan Oncology LLC (CGEM) Stock Forecast

Show ratings and price targets of :
USD 32.55
(+108.49%)

Based on the Cullinan Oncology LLC stock forecast from 4 analysts, the average analyst target price for Cullinan Oncology LLC is USD 32.55 over the next 12 months. Cullinan Oncology LLC’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Cullinan Oncology LLC is Slightly Bearish, which is based on 1 positive signals and 2 negative signals. At the last closing, Cullinan Oncology LLC’s stock price was USD 15.61. Cullinan Oncology LLC’s stock price has changed by -11.36% over the past week, -6.13% over the past month and +85.61% over the last year.

No recent analyst target price found for Cullinan Oncology LLC
No recent average analyst rating found for Cullinan Oncology LLC

Company Overview Cullinan Oncology LLC

N/A

N/A

N/A

N/A

USD

USA

Adjusted Closing Price for Cullinan Oncology LLC (CGEM)

Loading...

Unadjusted Closing Price for Cullinan Oncology LLC (CGEM)

Loading...

Share Trading Volume for Cullinan Oncology LLC Shares

Loading...

Compare Performance of Cullinan Oncology LLC Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for CGEM

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Cullinan Oncology LLC (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc -4.86 (-1.02%) USD125.13B 32.57 256.87

Frequently Asked Questions About Cullinan Oncology LLC (CGEM) Stock

Based on ratings from 4 analysts Cullinan Oncology LLC's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 11 buy, sell and hold ratings.

Unfortunately we do not have enough data on CGEM's stock to indicate if its a good dividend stock.

Based on targets from 4 analysts, the average taret price for CGEM is USD 32.55 over the next 12 months. The maximum analyst target price is USD 40 while the minimum anlayst target price is USD 28.

Unfortunately we do not have enough data on CGEM's stock to indicate if its overvalued.

The last closing price of CGEM's stock was USD 15.61.

Unfortunately we do not currently have any market capitalization data for CGEM's stock.

Based on targets from 4 analysts, the average taret price for CGEM is projected at USD 32.55 over the next 12 months. This means that CGEM's stock price may go up by +108.49% over the next 12 months.

We can't find any ETFs which contains Cullinan Oncology LLC's stock.

Sorry, we do not have any data on the number of employees for Cullinan Oncology LLC.

Sorry we do not have any infomation available on Cullinan Oncology LLC's address.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Frequently Asked Questions About Cullinan Oncology LLC (CGEM) Stock

Based on ratings from 4 analysts Cullinan Oncology LLC's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 11 buy, sell and hold ratings.

Unfortunately we do not have enough data on CGEM's stock to indicate if its a good dividend stock.

Based on targets from 4 analysts, the average taret price for CGEM is USD 32.55 over the next 12 months. The maximum analyst target price is USD 40 while the minimum anlayst target price is USD 28.

Unfortunately we do not have enough data on CGEM's stock to indicate if its overvalued.

The last closing price of CGEM's stock was USD 15.61.

Unfortunately we do not currently have any market capitalization data for CGEM's stock.

Based on targets from 4 analysts, the average taret price for CGEM is projected at USD 32.55 over the next 12 months. This means that CGEM's stock price may go up by +108.49% over the next 12 months.

We can't find any ETFs which contains Cullinan Oncology LLC's stock.

Sorry, we do not have any data on the number of employees for Cullinan Oncology LLC.

Sorry we do not have any infomation available on Cullinan Oncology LLC's address.
Loading...